AIV Logo AIV Assistant

Loading...

 Logo Aethlon Medical, Inc. - AEMD Open Aethlon Medical, Inc. in new tab

4.30 USD
EPS
-66.70
P/B
0.40
ROE
-207.29
Beta
1.83
Target Price
12.38 USD

4.3000 USD

4.300 USD

Daily: -4.66%
Key Metrics

Earnings date: Nov. 12, 2025

EPS: -66.70

Book Value: 13.17

Price to Book: 0.40

Debt/Equity: 20.06

% Insiders: 3.393%

Estimates

Forward P/E: -7.97

Forward EPS: -0.66

Target Mean Price: 12.38

DCF Valuation

Tweak assumptions to recompute fair value for Aethlon Medical, Inc. (AEMD)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

 Logo About Aethlon Medical, Inc. - (AEMD)

Country: United States

Sector: Health Care

Website: http://www.aethlonmedical.com

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Exchange Ticker
NCM (Australia) AEMD

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
April 14, 2015 0.020000
Oct. 15, 2019 0.070000
Oct. 5, 2023 0.100000
June 9, 2025 0.120000
Oct. 20, 2025 0.100000
Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion